Microvesicles from Human Adipose Tissue-Derived Mesenchymal Stem Cells as a New Protective Strategy in Osteoarthritic Chondrocytes

Cited by papers we hold 10

• Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages · 2022
  No notice
• Therapeutic effects of bone marrow mesenchymal stem cells‐derived exosomes on osteoarthritis · 2021
  No notice
• Adipose-Derived Stem Cells Secretome and Its Potential Application in “Stem Cell-Free Therapy” · 2021
  No notice
• Mesenchymal Stem Cell–Derived Exosomes: A Promising Biological Tool in Nanomedicine · 2021
  No notice
• Extracellular vesicles derived from different sources of mesenchymal stem cells: therapeutic effects and translational potential · 2020
  No notice
• Exosomes: roles and therapeutic potential in osteoarthritis · 2020
  No notice
• Exosomes derived from platelet-rich plasma present a novel potential in alleviating knee osteoarthritis by promoting proliferation and inhibiting apoptosis of chondrocyte via Wnt/β-catenin signaling pathway · 2019
  No notice
• Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis? · 2019
  No notice
• Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome · 2019
  No notice
• Extracellular Vesicles and Matrix Remodeling Enzymes: The Emerging Roles in Extracellular Matrix Remodeling, Progression of Diseases and Tissue Repair · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.